603087 甘李药业
已收盘 08-15 15:00:00
资讯
新帖
简况
每周股票复盘：甘李药业（603087）股东及董事完成减持计划
证券之星 · 08-16 19:12
每周股票复盘：甘李药业（603087）股东及董事完成减持计划
甘李药业：三款胰岛素类似物产品通过EMA上市前GMP检查
证券之星 · 08-15 09:36
甘李药业：三款胰岛素类似物产品通过EMA上市前GMP检查
研报掘金丨华安证券：维持甘李药业“买入”评级，海外市场保持高增长
格隆汇 · 08-14
研报掘金丨华安证券：维持甘李药业“买入”评级，海外市场保持高增长
甘李药业：8月11日至8月12日高管焦娇减持股份合计5.75万股
证券之星 · 08-13
甘李药业：8月11日至8月12日高管焦娇减持股份合计5.75万股
研报掘金丨东方证券：维持甘李药业“买入”评级，目标价70.67元
格隆汇 · 08-13
研报掘金丨东方证券：维持甘李药业“买入”评级，目标价70.67元
11.8清仓涪陵电力，获利38.8%！
滇南王 · 08-12
11.8清仓涪陵电力，获利38.8%！
速递｜甘李药业基础胰岛素/GLP-1RA固定比例复方长效周制剂中国 II 期临床完成首例给药
GLP1减重宝典 · 08-10
速递｜甘李药业基础胰岛素/GLP-1RA固定比例复方长效周制剂中国 II 期临床完成首例给药
创新药企上半年业绩频报喜行业步入发展新阶段
动脉网 · 08-09
创新药企上半年业绩频报喜行业步入发展新阶段
甘李药业（603087）2025年中报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 08-08
甘李药业（603087）2025年中报简析：营收净利润同比双双增长，盈利能力上升
甘李药业公布国际专利申请：“抗Nectin-4抗体、配体药物偶联物及其应用”
证券之星 · 08-08
甘李药业公布国际专利申请：“抗Nectin-4抗体、配体药物偶联物及其应用”
上海银行新增一起对外投资，被投资公司为甘李药业股份有限公司
证券之星APP · 08-08
上海银行新增一起对外投资，被投资公司为甘李药业股份有限公司
【聚焦】胰岛素国内龙头净利润大涨102%，抢攻70亿大品种
米内网 · 08-08
【聚焦】胰岛素国内龙头净利润大涨102%，抢攻70亿大品种
甘李药业(603087.SH)：GZR102注射液Ⅱ期临床试验完成首例受试者给药
智通财经 · 08-08
甘李药业(603087.SH)：GZR102注射液Ⅱ期临床试验完成首例受试者给药
国金证券：给予甘李药业买入评级
证券之星 · 08-08
国金证券：给予甘李药业买入评级
甘李药业上半年净利润同比翻倍；国内首个呼吸生物制剂新增儿童适应证
每日经济新闻 · 08-07
甘李药业上半年净利润同比翻倍；国内首个呼吸生物制剂新增儿童适应证
甘李药业最新公告：2025年半年度净利润同比增长101.96%
证券之星 · 08-07
甘李药业最新公告：2025年半年度净利润同比增长101.96%
甘李药业股价上涨1.05% 盘中快速反弹超2%
金融界 · 08-06
甘李药业股价上涨1.05% 盘中快速反弹超2%
独家药品概念盘中跳水，以岭药业跌0.18%
市场透视 · 08-06
独家药品概念盘中跳水，以岭药业跌0.18%
减肥药概念股回暖，美诺华涨停
钛媒体 · 08-05
减肥药概念股回暖，美诺华涨停
减肥药概念盘中拉升，翰宇药业涨7.57%
市场透视 · 08-05
减肥药概念盘中拉升，翰宇药业涨7.57%
加载更多
公司概况
公司名称：
甘李药业股份有限公司
所属行业：
医药制造业
上市日期：
2020-06-29
主营业务：
甘李药业股份有限公司的主营业务是胰岛素类似物原料药及注射剂研发、生产和销售。公司的主要产品是生物制品(原料药及制剂产品)、化药、医疗器械及其他、特许权服务。2025年5月，公司被纳入标普全球《可持续发展年鉴（中国版）2025》，同时被授予“行业最佳进步企业”的荣誉称号。
发行价格：
63.32
{"stockData":{"symbol":"603087","market":"SH","secType":"STK","nameCN":"甘李药业","latestPrice":62.5,"timestamp":1755241201000,"preClose":62.04,"halted":0,"volume":12427932,"delay":0,"changeRate":0.0074,"floatShares":561000000,"shares":601000000,"eps":1.5297,"marketStatus":"已收盘","change":0.46,"latestTime":"08-15 15:00:00","open":61.92,"high":62.99,"low":61.73,"amount":775000000,"amplitude":0.0203,"askPrice":62.51,"askSize":34,"bidPrice":62.5,"bidSize":115,"shortable":0,"etf":0,"ttmEps":1.5297,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1755480600000},"marketStatusCode":5,"adr":0,"adjPreClose":62.04,"symbolType":"stock","openAndCloseTimeList":[[1755221400000,1755228600000],[1755234000000,1755241200000]],"highLimit":68.24,"lowLimit":55.84,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":601065290,"isCdr":false,"pbRate":3.43,"roa":"--","peRate":40.857685,"roe":"5.32%","epsLYR":1.04,"committee":0.377246,"marketValue":37567000000,"turnoverRate":0.0221,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-08-18。","floatMarketCap":35087000000},"requestUrl":"/m/hq/s/603087","defaultTab":"news","newsList":[{"id":"2560925166","title":"每周股票复盘：甘李药业（603087）股东及董事完成减持计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2560925166","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560925166?lang=zh_cn&edition=full","pubTime":"2025-08-17 03:12","pubTimestamp":1755371534,"startTime":"0","endTime":"0","summary":"截至2025年8月15日收盘，甘李药业报收于62.5元，较上周的61.48元上涨1.66%。高管增减持根据8月13日市场公开信息、上市公司公告及交易所披露数据整理，甘李药业最新董监高及相关人员股份变动情况：2025年8月11日至2025年8月12日公司董事焦娇共减持公司股份5.75万股，占公司总股本为0.0096%。甘李药业股份有限公司股东及董事减持股份结果公告。甘李药业股份有限公司董事会2025年8月16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700000412.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603087"],"gpt_icon":0},{"id":"2559913476","title":"甘李药业：三款胰岛素类似物产品通过EMA上市前GMP检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2559913476","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559913476?lang=zh_cn&edition=full","pubTime":"2025-08-15 17:36","pubTimestamp":1755250573,"startTime":"0","endTime":"0","summary":"证券之星消息，甘李药业08月15日在投资者关系平台上答复投资者关心的问题。具体业绩情况请以公司后续披露的定期报告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081500033719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603087"],"gpt_icon":0},{"id":"2559931746","title":"研报掘金丨华安证券：维持甘李药业“买入”评级，海外市场保持高增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2559931746","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559931746?lang=zh_cn&edition=full","pubTime":"2025-08-14 13:54","pubTimestamp":1755150886,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["603087","BK0276","600909","BK0201","BK0239","BK0183"],"gpt_icon":0},{"id":"2559046616","title":"甘李药业：8月11日至8月12日高管焦娇减持股份合计5.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2559046616","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559046616?lang=zh_cn&edition=full","pubTime":"2025-08-13 20:02","pubTimestamp":1755086520,"startTime":"0","endTime":"0","summary":"证券之星消息，根据8月13日市场公开信息、上市公司公告及交易所披露数据整理，甘李药业最新董监高及相关人员股份变动情况：2025年8月11日至2025年8月12日公司董事焦娇共减持公司股份5.75万股，占公司总股本为0.0096%。甘李药业近半年内的董监高及核心技术人员增减持详情如下：甘李药业的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入9382.6万，融资余额增加；融券净流入5000.0，融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081300034798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603087"],"gpt_icon":0},{"id":"2559674045","title":"研报掘金丨东方证券：维持甘李药业“买入”评级，目标价70.67元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559674045","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559674045?lang=zh_cn&edition=full","pubTime":"2025-08-13 14:47","pubTimestamp":1755067663,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0183","BK1147","BK4590","600958","BK0012","603087","03958","BK0239","BK0276","III","GLP","BK4134","BK1564","BK0028","BK0188","BK4144"],"gpt_icon":0},{"id":"2558611277","title":"11.8清仓涪陵电力，获利38.8%！","url":"https://stock-news.laohu8.com/highlight/detail?id=2558611277","media":"滇南王","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558611277?lang=zh_cn&edition=full","pubTime":"2025-08-12 15:06","pubTimestamp":1754982383,"startTime":"0","endTime":"0","summary":"今天11.8清仓涪陵电力，获利38.8%，对我来说，我是很知足的，因为埋伏不到两年，能取得这个成绩，已经超我预期了！看好国家电网，12.4建仓涪陵电力！甘李药业现在61，也就是如果当时不走，拿着甘李药业，现在也有31%的利润，换成涪陵电力后，多了7%的收益，但是更重要的是，心安心好多！最近几年，涪陵电力净利润5亿左右，按照12元算，市值185亿，按照5亿净利润算，市盈率37倍，这个市盈率，明显不符合我的投资体系，所以才考虑撤退！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812152041a6e11dd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812152041a6e11dd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0179","BK0271","600452","600995","603087","BK0186","BK0175","BK0102"],"gpt_icon":0},{"id":"2558649686","title":"速递｜甘李药业基础胰岛素/GLP-1RA固定比例复方长效周制剂中国 II 期临床完成首例给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2558649686","media":"GLP1减重宝典","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558649686?lang=zh_cn&edition=full","pubTime":"2025-08-10 17:27","pubTimestamp":1754818050,"startTime":"0","endTime":"0","summary":"目前，全球尚无此类固定比例复方长效周制剂上市，GZR102 在短时间内进入 II 期临床，或将成为中国在糖尿病联合治疗领域的潜在优选产品，进一步丰富甘李药业的产品布局。关于 GZR102 注射液GZR102 注射液由甘李药业自主研发，是一款基础胰岛素/GLP-1RA 固定比例复方长效周制剂，由胰岛素长效周制剂 GZR4 与 GLP-1RA 博凡格鲁肽按固定比例组成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810173622a47fec20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810173622a47fec20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603087","BK0239"],"gpt_icon":0},{"id":"2558503599","title":"创新药企上半年业绩频报喜行业步入发展新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2558503599","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558503599?lang=zh_cn&edition=full","pubTime":"2025-08-09 09:39","pubTimestamp":1754703540,"startTime":"0","endTime":"0","summary":"多家创新药企在2025年上半年交出了亮眼的业绩报告，标志着行业正从依赖国内市场和仿制药模式向以原始创新和全球注册为核心的新阶段转变。甘李药业实现营收20.67亿元，同比增长57.18%，净利润6.04亿元，同比增长101.96%；百济神州首次半年度实现盈利，归母净利润4.50亿元，主要得益于自主研发产品如百悦泽®和安进授权产品的销售增长；乐普生物预计上半年利润不少于2400万元，首次实现盈利，收入增长主要来自许可合作及普特利单抗注射液的销售收入。此外，国家政策支持也推动了创新药的发展，包括鼓励商业健康保险扩大投资规模等措施。这些积极信号表明，中国创新药行业正在迎来新的发展机遇。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809094416973cf497&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809094416973cf497&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","603087","02157","BK1500","LU0307460666.USD","LU1969619763.USD","BK1588","LU0588546209.SGD","LU2328871848.SGD","BK1161","BK1583","688235","BK1574","06160","06978"],"gpt_icon":0},{"id":"2558288577","title":"甘李药业（603087）2025年中报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2558288577","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558288577?lang=zh_cn&edition=full","pubTime":"2025-08-09 06:02","pubTimestamp":1754690562,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期甘李药业发布2025年中报。截至本报告期末，公司营业总收入20.67亿元，同比上升57.18%，归母净利润6.04亿元，同比上升101.96%。本报告期甘李药业盈利能力上升，毛利率同比增幅3.81%，净利率同比增幅28.49%。此外，公司国内制剂整体销量同比增长33.55%，各制剂产品均呈现积极增长态势。持有甘李药业最多的基金为南方阿尔法混合A，目前规模为25.67亿元，最新净值0.5928，较上一交易日下跌0.3%，近一年上涨29.91%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080900004687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087"],"gpt_icon":0},{"id":"2558572042","title":"甘李药业公布国际专利申请：“抗Nectin-4抗体、配体药物偶联物及其应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2558572042","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558572042?lang=zh_cn&edition=full","pubTime":"2025-08-09 05:06","pubTimestamp":1754687169,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示甘李药业（603087）公布了一项国际专利申请，专利名为“抗Nectin-4抗体、配体药物偶联物及其应用”，专利申请号为PCT/CN2025/075858，国际公布日为2025年8月7日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来甘李药业已公布的国际专利申请11个，较去年同期增加了22.22%。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了2.65亿元，同比减0.73%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080900004323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603087"],"gpt_icon":0},{"id":"2558728975","title":"上海银行新增一起对外投资，被投资公司为甘李药业股份有限公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2558728975","media":"证券之星APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558728975?lang=zh_cn&edition=full","pubTime":"2025-08-09 03:59","pubTimestamp":1754683190,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP显示，上海银行新增一起对外投资事件，被投资公司为甘李药业股份有限公司，法定代表人陈伟，投资占比为0.57%。该公司从事医药制造业，注册资本为60106.529万人民币。据2024年报数据，上海银行长期股权投资10.68亿元，同比增10.93%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809040227973c7ad1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809040227973c7ad1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["601229","BK0020","SGXZ81163826.USD","BK0278","BK0239","BK0188","SGXZ49509284.SGD","LU1934453819.USD","603087","BK0187","LU1979443071.USD","BK0183"],"gpt_icon":0},{"id":"2557109541","title":"【聚焦】胰岛素国内龙头净利润大涨102%，抢攻70亿大品种","url":"https://stock-news.laohu8.com/highlight/detail?id=2557109541","media":"米内网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557109541?lang=zh_cn&edition=full","pubTime":"2025-08-08 16:06","pubTimestamp":1754640411,"startTime":"0","endTime":"0","summary":"精彩内容8月8日，胰岛素国内龙头之一的甘李药业发布了2025年半年报，营业收入突破20亿元，净利润大涨101.96%，创近五年同期新高。前几日，公司提交了达格列净片的4类仿制上市申请，将为公司的糖尿病用药矩阵再添重磅一员，该产品2024年在中国三大终端六大市场销售额超过70亿元。图3：近五年上半年甘李药业的业绩情况来源：东方财富网8月8日，甘李药业发布了2025上半年年报，公司营业收入突破20亿元，净利润大涨101.96%，成绩喜人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808162230a6da960a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808162230a6da960a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603087"],"gpt_icon":0},{"id":"2557709545","title":"甘李药业(603087.SH)：GZR102注射液Ⅱ期临床试验完成首例受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2557709545","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557709545?lang=zh_cn&edition=full","pubTime":"2025-08-08 15:32","pubTimestamp":1754638368,"startTime":"0","endTime":"0","summary":"智通财经APP讯，甘李药业 发布公告，公司全资子公司甘李药业山东有限公司自主研发的GZR102注射液正在中国开展Ⅱ期临床试验，于近日成功完成首例受试者给药。GZR102注射液是一种基础胰岛素/GLP-1RA固定比例复方周制剂，由胰岛素周制剂GZR4和GLP-1RA博凡格鲁肽以固定比例组成。作为每周一次皮下注射制剂，GZR102注射液通过创新配方将两种药物成分的协同作用最大化。目前，GZR102的全球开发已进入Ⅱ期临床阶段。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1327268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"甘李药业(603087.SH)：GZR102注射液Ⅱ期临床试验完成首例受试者给药","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603087","BK0239"],"gpt_icon":0},{"id":"2557015590","title":"国金证券：给予甘李药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2557015590","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557015590?lang=zh_cn&edition=full","pubTime":"2025-08-08 08:45","pubTimestamp":1754613926,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,马居东近期对甘李药业进行研究并发布了研究报告《制剂业务持续高增，研发及国际化稳步推进》，给予甘李药业买入评级。公司国内制剂整体销量同比增长33.55%，各制剂产品均呈现积极增长态势。2025年上半年研发投入达5.52亿元，占营业收入比例26.70%。维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家；过去90天内机构目标均价为70.67。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080800006143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087"],"gpt_icon":0},{"id":"2557597359","title":"甘李药业上半年净利润同比翻倍；国内首个呼吸生物制剂新增儿童适应证","url":"https://stock-news.laohu8.com/highlight/detail?id=2557597359","media":"每日经济新闻","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557597359?lang=zh_cn&edition=full","pubTime":"2025-08-08 07:17","pubTimestamp":1754608664,"startTime":"0","endTime":"0","summary":"NO.3国内首个呼吸生物制剂新增儿童适应证8月7日，阿斯利康宣布，其中国首个呼吸生物制剂凡舒卓新适应证在中国正式批准，用于儿童重度嗜酸粒细胞性哮喘的维持治疗。NO.4甘李药业上半年净利润同比增加101.96%8月7日，甘李药业发布2025年半年度报告，公司实现营业收入20.67亿元，同比增加57.18%；实现归母净利润6.04亿元，同比增加101.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808072106973a8851&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808072106973a8851&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603087","AZN","01801","LLY","603858"],"gpt_icon":0},{"id":"2557559436","title":"甘李药业最新公告：2025年半年度净利润同比增长101.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557559436","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557559436?lang=zh_cn&edition=full","pubTime":"2025-08-07 18:20","pubTimestamp":1754562051,"startTime":"0","endTime":"0","summary":"甘李药业(603087.SH)公告称，2025年上半年实现营业收入20.67亿元，同比增长57.18%；净利润6.04亿元，同比增长101.96%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080700031955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087"],"gpt_icon":0},{"id":"2557306278","title":"甘李药业股价上涨1.05% 盘中快速反弹超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557306278","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557306278?lang=zh_cn&edition=full","pubTime":"2025-08-07 00:13","pubTimestamp":1754496804,"startTime":"0","endTime":"0","summary":"截至2025年8月6日收盘，甘李药业股价报64.36元，较前一交易日上涨1.05%。当日盘中出现快速反弹，5分钟内涨幅超过2%，最高触及65.90元。全天成交额达13.22亿元，换手率为3.65%。甘李药业是一家专注于生物制药领域的公司，主要从事糖尿病治疗药物的研发、生产和销售。公司产品涵盖胰岛素类似物、人胰岛素等多个系列。从资金流向来看，8月6日主力资金净流入6982.68万元，近五日累计净流入1.53亿元。当前公司总市值为386.85亿元，流通市值361.32亿元。风险提示：股市有风险，投资需谨慎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508070016549737c85a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508070016549737c85a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603087"],"gpt_icon":0},{"id":"2557346753","title":"独家药品概念盘中跳水，以岭药业跌0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557346753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557346753?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:50","pubTimestamp":1754445036,"startTime":"0","endTime":"0","summary":"08月06日，独家药品概念盘中跳水，截至09点50分，独家药品概念整体指数下跌0.60%，报1069.900点。从个股上来看，该概念的成分股中，以岭药业跌0.18%，通化东宝跌幅居前。从资金上来看，截止发稿，独家药品概念概念主力净流入为137.04万，其中甘李药业受到资金热捧，主力净流入6031.51万；拉长时间线来看，该板块近20日主力资金净流入-28.21亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806095036a4779bd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806095036a4779bd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","BK0042","BK0239","BK0097","603087","BK0188","002603"],"gpt_icon":0},{"id":"2557356233","title":"减肥药概念股回暖，美诺华涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2557356233","media":"钛媒体","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557356233?lang=zh_cn&edition=full","pubTime":"2025-08-05 09:47","pubTimestamp":1754358420,"startTime":"0","endTime":"0","summary":"钛媒体App 8月5日消息，减肥药概念股回暖，美诺华涨停，翰宇药业、金凯生科、甘李药业、四川双马、丰原药业、常山药业等跟涨。（科股宝播报）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805102559a6d37986&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805102559a6d37986&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603538","BK0239","603087"],"gpt_icon":0},{"id":"2557119355","title":"减肥药概念盘中拉升，翰宇药业涨7.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557119355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557119355?lang=zh_cn&edition=full","pubTime":"2025-08-05 09:36","pubTimestamp":1754357802,"startTime":"0","endTime":"0","summary":"08月05日，减肥药概念盘中拉升，截至09点36分，减肥药概念整体指数上涨1.02%，报1293.480点。从个股上来看，该概念的成分股中，翰宇药业涨7.57%，美诺华涨幅超过5%。从资金上来看，截止发稿，减肥药概念主力净流入为-2.12亿，其中甘李药业受到资金热捧，主力净流入3135.26万；拉长时间线来看，该板块近20日主力资金净流入-53.15亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805093642a475704e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805093642a475704e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300199","BK0077","BK0070","BK0188","BK0028","603538","BK0239","603087"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1755423924106,"stockEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":0.0896},{"period":"3month","weight":0.2478},{"period":"6month","weight":0.4332},{"period":"1year","weight":0.5036},{"period":"ytd","weight":0.4416}],"compareEarnings":[{"period":"1week","weight":0.017},{"period":"1month","weight":0.0551},{"period":"3month","weight":0.0978},{"period":"6month","weight":0.1046},{"period":"1year","weight":0.2848},{"period":"ytd","weight":0.1029}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"甘李药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"77299人(较上一季度增加3.08%)","perCapita":"7262股","listingDate":"2020-06-29","address":"北京市通州区漷县镇南凤西一路8号","registeredCapital":"60106万元","survey":" 甘李药业股份有限公司的主营业务是胰岛素类似物原料药及注射剂研发、生产和销售。公司的主要产品是生物制品(原料药及制剂产品)、化药、医疗器械及其他、特许权服务。2025年5月，公司被纳入标普全球《可持续发展年鉴（中国版）2025》，同时被授予“行业最佳进步企业”的荣誉称号。","listedPrice":63.32},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.8","shortVersion":"4.34.8","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"甘李药业(603087)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供甘李药业(603087)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"甘李药业,603087,甘李药业股票,甘李药业股票老虎,甘李药业股票老虎国际,甘李药业行情,甘李药业股票行情,甘李药业股价,甘李药业股市,甘李药业股票价格,甘李药业股票交易,甘李药业股票购买,甘李药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"甘李药业(603087)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供甘李药业(603087)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}